Back to Search Results
Image Place holder

Krupal Patel, MD, MSc, FRCS(C)

★★★★★
★★★★★
4.8 (128 ratings)
Specialty: Head and Neck Surgery
Program: Head and Neck Oncology

Call 1-888-663-3488

Call 1-888-663-3488


Locations:
Overview

Cancer Focus: Basal Cell Carcinoma, Head and Neck Cancer, Melanoma, Merkel Cell Carcinoma, Oral Cavity or Throat Cancer, Pituitary Macroadenoma, Pituitary Microadenoma, Pituitary Neoplasm, Skin Cancer (Nonmelanoma), Squamous Cell Carcinoma, Throat Cancer, Thyroid Cancer, Tongue Cancer

Dr. Krupal Patel is an Assistant Member in the Department of Head and Neck–Endocrine Oncology. Dr. Patel received his MD degree at the College of Medicine, University of Saskatchewan. He concurrently completed a Residency in the Department of Otolaryngology–Head and Neck Surgery, and a Master of Science degree in Surgery at Western University, London, Ontario, Canada. He is board-certified in Otolaryngology by the Royal College of Physicians and Surgeons in Canada. He went on to complete the Head and Neck Microvascular Reconstruction Fellowship at The Ohio State University Wexner Medical Center in Columbus, Ohio. Dr. Patel is a member of the American Head and Neck Society, North American Skull Base Society and Disparities Committee at NRG. Dr. Patel’s clinical interests include the management of oral cavity/oropharynx/larynx cancers, salivary gland neoplasms, thyroid cancers, reconstruction of melanoma and non-melanoma skin cancer defects in the head and neck region, and sinonasal cancers (cancers arising from nose and sinuses). His clinical research interests focus on the development of transoral robotic surgery and improvement in microvascular reconstructive surgeries for head and neck cancers. He has ongoing projects and publications in cancer care delivery including virtual health and real time patient monitoring to design just-in-time interventions to improve patient outcomes. Dr. Patel’s translational research focuses on developing biomarkers for use in genomic analyses that predict the impact of therapeutic interventions on clinical and quality-of-life outcomes. 


Education & Training

Fellowship:

  • Ohio State University - Head and Neck Microvascular Reconstruction

Residency:

  • Western University, London, ON, Canada - Head and Neck Surgery

Medical School:

  • University of Saskatchewan, SK, Canada - MD
Participating Trials

If you believe you are eligible for one of these trials or studies, please call
813-745-6100 or toll-free 1-800-679-0775.

Publications

  • Patel KB, Prokopec S, Barrett JW, Mymryk JS, Boutros PC, Nichols AC. Establishment of four head and neck squamous cell carcinoma cell lines: importance of reference DNA for accurate genomic characterisation. J Laryngol Otol. 2023 Mar.137(3):301-307. Pubmedid: 35317874. Pmcid: PMC9975763.
  • Nguyen OT, Mason A, Khanna N, Charles D, Naso C, Hong YR, Sprow O, Alishahi Tabriz A, Turner K, Spiess P, Patel KB. Patient and caregiver experience with telehealth for surgical cancer care: A qualitative study. J Surg Oncol. 2023 Mar. Pubmedid: 36883752.
  • Patel KB, Turner K, Alishahi Tabriz A, Gonzalez BD, Oswald LB, Nguyen OT, Hong YR, Jim HSL, Nichols AC, Wang X, Robinson E, Naso C, Spiess PE. Estimated Indirect Cost Savings of Using Telehealth Among Nonelderly Patients With Cancer. JAMA Netw Open. 2023 Jan.6(1):e2250211. Pubmedid: 36626174. Pmcid: PMC9856804.
  • Patel KB, Padhya TA, Huang J, Hernandez-Prera JC, Li T, Chung CH, Wang L, Wang X. Plasma cell-free DNA methylome profiling in pre- and post-surgery oral cavity squamous cell carcinoma. Mol Carcinogen. 2023 Jan. Pubmedid: 36636912.
  • Patel KB, Gonzalez BD, Turner K, Alishahi Tabriz A, Rollison DE, Robinson E, Naso C, Wang X, Spiess PE. Estimated Carbon Emissions Savings With Shifts From In-Person Visits to Telemedicine for Patients With Cancer. JAMA Netw Open. 2023 Jan.6(1):e2253788. Pubmedid: 36719682. Pmcid: PMC9890284.
  • Cao B, Patel KB, Li T, Yao S, Chung CH, Wang X. A subnetwork-based framework for prioritizing and evaluating prognostic gene modules from cancer transcriptome data. iScience. 2023 Feb.26(2):105915. Pubmedid: 36685033. Pmcid: PMC9845797.
  • Patel KB, Silverman D, Barron C, Ozer E. Anterolateral thigh butterfly free flap for reconstruction of laryngopharyngeal defect: surgical considerations. J Laryngol Otol. 2022 Sep.136(9):878-881. Pubmedid: 35388772.
  • Oswald LB, Arredondo B, Geiss C, Vigoureux TFD, Hoogland AI, Chung CH, Muzaffar J, Patel KB, Gonzalez BD, Jim HSL, Kirtane K. Considerations for developing supportive care interventions for survivors of head and neck cancer: A qualitative study. Psychooncology. 2022 Sep.31(9):1519-1526. Pubmedid: 35726386. Pmcid: PMC9452460.
  • Liu JKC, Kang R, Bilenkin A, Prorok R, Whiting J, Patel KB, Beer-Furlan A, Naso C, Rogers A, Castro XB, Peguero E, Mokhtari S, Tran N, Etame A, Pina Y, Spiess PE, Forsyth P, Vogelbaum MA. Patient satisfaction and cost savings analysis of the telemedicine program within a neuro-oncology department. J Neurooncol. 2022 Nov.160(2):517-525. Pubmedid: 36367630. Pmcid: PMC9651094.
  • Turner K, Stover AM, Tometich DB, Geiss C, Mason A, Nguyen OT, Hume E, McCormick R, Powell S, Hallanger-Johnson J, Patel KB, Kirtane KS, Jammigumpula N, Moore C, Perkins R, Rollison DE, Jim HSL, Oswald LB, Crowder S, Gonzalez BD, Robinson E, Tabriz AA, Islam JY, Gilbert SM. Oncology Providers' and Professionals' Experiences With Suicide Risk Screening Among Patients With Head and Neck Cancer: A Qualitative Study. JCO Oncol Pract. 2022 Nov.OP2200433. Pubmedid: 36395441.
  • Kirtane K, Geiss C, Arredondo B, Hoogland AI, Chung CH, Muzaffar J, Patel KB, Gonzalez BD, Jim HSL, Oswald LB. "I have cancer during COVID; that's a special category": a qualitative study of head and neck cancer patient and provider experiences during the COVID-19 pandemic. Support Care Cancer. 2022 May.30(5):4337-4344. Pubmedid: 35091844. Pmcid: PMC8799415.
  • Kim HAJ, Zeng PYF, Sorgini A, Shaikh MH, Khan H, MacNeil D, Khan MI, Mendez A, Yoo J, Fung K, Lang P, Palma DA, Mymryk JS, Barrett JW, Patel KB, Boutros PC, Nichols AC. Tumor molecular differences associated with outcome disparities of Black patients with head and neck cancer. Head Neck. 2022 May.44(5):1124-1135. Pubmedid: 35187756. Pmcid: PMC9047510.
  • Turner K, Bobonis Babilonia M, Naso C, Nguyen O, Gonzalez BD, Oswald LB, Robinson E, Elston Lafata J, Ferguson RJ, Alishahi Tabriz A, Patel K, Hallanger-Johnson J, Aldawoodi N, Hong YR, Jim HSL, Speiss PE. Health Care Providers' and Professionals' Experiences With Telehealth Oncology Implementation During the COVID-19 Pandemic: A Qualitative Study. J Med Internet Res. 2022 Jan.24(1):e29635. Pubmedid: 34907900. Pmcid: PMC8772877.
  • Shabani S, Turner K, Nichols AC, Wang X, Patel KB. A Review of Health Care Disparities in Head and Neck Squamous Cell Carcinomas. J Health Care Poor Underserved. 2022 Feb.33(1):478-491. Pubmedid: 35153235.
  • Nguyen OT, McCormick R, Patel K, Reblin M, Kim L, Hume E, Powers B, Otto A, Alishahi Tabriz A, Islam J, Hong YR, Kirchhoff AC, Turner K. Health insurance literacy among head and neck cancer patients and their caregivers: A cross-sectional pilot study. Laryngoscope Investig Otolaryngol. 2022 Dec.7(6):1820-1829. Pubmedid: 36544972. Pmcid: PMC9764792.
  • Patel KB, Shabani S, Padhya T, Cao B, Wang X, Turner K, Nichols AC, Kang SY, Rocco JW, Old M. The Impact of the Affordable Care Act on Insurance Coverage and Stage Among Head and Neck Squamous Cell Carcinoma Patients. J Health Care Poor Underserved. 2022 Aug.33(3):1322-1336. Pubmedid: 36245166.
  • Patel KB, Mroz EA, Faquin WC, Rocco JW. A combination of intra-tumor genetic heterogeneity, estrogen receptor alpha and human papillomavirus status predicts outcomes in head and neck squamous cell carcinoma following chemoradiotherapy. Oral Oncol. 2021 Sep.120:105421. Pubmedid: 34198234.
  • Kim HAJ, Shaikh MH, Lee M, Zeng PYF, Sorgini A, Akintola T, Deng X, Jarycki L, Khan H, MacNeil D, Khan MI, Mendez A, Yoo J, Fung K, Lang P, Palma DA, Patel K, Mymryk JS, Barrett JW, Boutros PC, Morris LGT, Nichols AC. 3p Arm Loss and Survival in Head and Neck Cancer: An Analysis of TCGA Dataset. Cancers (Basel). 2021 Oct.13(21). Pubmedid: 34771477. Pmcid: PMC8582539.
  • Clay I, Angelopoulos C, Bailey AL, Blocker A, Carini S, Carvajal R, Drummond D, McManus KF, Oakley-Girvan I, Patel KB, Szepietowski P, Goldsack JC. Sensor Data Integration: A New Cross-Industry Collaboration to Articulate Value, Define Needs, and Advance a Framework for Best Practices. J Med Internet Res. 2021 Nov.23(11):e34493. Pubmedid: 34751656. Pmcid: PMC8663457.
  • Kim HAJ, Zeng PYF, Shaikh MH, Mundi N, Ghasemi F, Di Gravio E, Khan H, MacNeil D, Khan MI, Patel K, Mendez A, Yoo J, Fung K, Lang P, Palma DA, Mymryk JS, Barrett JW, Boutros PC, Nichols AC. All HPV-negative head and neck cancers are not the same: Analysis of the TCGA dataset reveals that anatomical sites have distinct mutation, transcriptome, hypoxia, and tumor microenvironment profiles. Oral Oncol. 2021 May.116:105260. Pubmedid: 33725617.
  • Chung CH, Bonomi M, Steuer CE, Li J, Bhateja P, Johnson M, Masannat J, Song F, Hernandez-Prera JC, Wenig BM, Molina H, Farinhas JM, McMullen CP, Wadsworth JT, Patel KB, Kish JA, Muzaffar J, Kirtane K, Rocco JW, Schell MJ, Saba NF. Concurrent Cetuximab and Nivolumab as a Second-Line or beyond Treatment of Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results of Phase I/II Study. Cancers (Basel). 2021 Mar.13(5). Pubmedid: 33803335. Pmcid: PMC7967147.
  • Turner K, Nguyen O, Hong YR, Tabriz AA, Patel K, Jim HSL. Use of Electronic Health Record Patient Portal Accounts Among Patients With Smartphone-Only Internet Access. JAMA Netw Open. 2021 Jul.4(7):e2118229. Pubmedid: 34309671. Pmcid: PMC8314137.
  • Patel KB, Martin D, Zhao S, Kumar B, Carrau R, Ozer E, Agrawal A, Kang S, Rocco JW, Schuller D, Teknos T, Brock G, Old M. Impact of age and comorbidity on survival among patients with oral cavity squamous cell carcinoma. Head Neck. 2021 Jan.43(1):268-277. Pubmedid: 32996249. Pmcid: PMC9017430.
  • Ziai H, Warner A, Mundi N, Patel K, Chung EJ, Howlett CJ, Plantinga P, Yoo J, MacNeil SD, Fung K, Mymryk JS, Barrett JW, Palma DA, Nichols AC. Does HPV Subtype Predict Outcomes in Head and Neck Cancers?. Int J Otolaryngol. 2021 Feb.2021:6672373. Pubmedid: 33824664. Pmcid: PMC8006754.
  • Shi LL, McMullen C, Vorwald K, Nichols AC, MacNeil SD, Wadsworth JT, Chung CH, Wang X, Patel KB. Survival outcomes of patients with subglottic squamous cell carcinoma : a study of the National Cancer Database. Eur Arch Otorhinolaryngol. 2021 Dec.278(12):4923-4932. Pubmedid: 33646344.
  • Sowerby LJ, Patel KB, Schmerk C, Rotenberg BW, Rocha T, Sommer DD. Effect of low salicylate diet on clinical and inflammatory markers in patients with aspirin exacerbated respiratory disease - a randomized crossover trial. J Otolaryngol Head Neck Surg. 2021 Apr.50(1):27. Pubmedid: 33892819. Pmcid: PMC8063291.
  • Pinto N, Prokopec SD, Ghasemi F, Meens J, Ruicci KM, Khan IM, Mundi N, Patel K, Han MW, Yoo J, Fung K, MacNeil D, Mymryk JS, Datti A, Barrett JW, Boutros PC, Ailles L, Nichols AC. Flavopiridol causes cell cycle inhibition and demonstrates anti-cancer activity in anaplastic thyroid cancer models. PLoS One. 2020 Sep.15(9):e0239315. Pubmedid: 32970704. Pmcid: PMC7514001.
  • Kassirian S, Dzioba A, Hamel S, Patel K, Sahovaler A, Palma DA, Read N, Venkatesan V, Nichols AC, Yoo J, Fung K, Mendez A, MacNeil SD. Delay in diagnosis of patients with head-and-neck cancer in Canada: impact of patient and provider delay. Curr Oncol. 2020 Oct.27(5):e467-e477. Pubmedid: 33173386. Pmcid: PMC7606041.
  • Kassirian S, Dzioba A, Hamel S, Patel K, Sahovaler A, Palma DA, Read N, Venkatesan V, Nichols AC, Yoo J, Fung K, Mendez A, MacNeil SD. Delay in Diagnosis of Patients with Head-and-Neck Cancer in Canada: Impact of Patient and Provider Delay. Curr Oncol. 2020 Oct.27(5):467-477. Pubmedid: 33704134.
  • Mundi N, Ghasemi F, Zeng PYF, Prokopec SD, Patel K, Kim HAJ, Di Gravio E, MacNeil D, Khan MI, Han MW, Shaikh M, Mendez A, Yoo J, Fung K, Gameiro SF, Palma DA, Mymryk JS, Barrett JW, Boutros PC, Nichols AC. Sex disparities in head & neck cancer driver genes: An analysis of the TCGA dataset. Oral Oncol. 2020 May.104:104614. Pubmedid: 32146388.
  • Vieira de Oliveira Silva S, Nabil A, Maza G, Shahein M, Vankoevering K, Patel KB, Prevedello D, Carrau R, Ozer E, Bertazo GS, Albonette Felicio T. Salvage Free Tissue Transfer for Clival Osteoradionecrosis After Repeat Proton Beam Therapy. World Neurosurg. 2020 Jun.138:485-490. Pubmedid: 32229304.
  • Mroz EA, Patel KB, Rocco JW. Intratumor heterogeneity could inform the use and type of postoperative adjuvant therapy in patients with head and neck squamous cell carcinoma. Cancer. 2020 Jan.126(9):1895-1904. Pubmedid: 32083741. Pmcid: PMC7160035.
  • Patel KB, Low TH, Partridge A, Nichols AC, MacNeil SD, Yoo J, Fung K. Assessment of shoulder function following scapular free flap. Head Neck. 2020 Feb.42(2):224-229. Pubmedid: 31657104.
  • Sorgini A, Kim HAJ, Zeng PYF, Shaikh MH, Mundi N, Ghasemi F, Di Gravio E, Khan H, MacNeil D, Khan MI, Mendez A, Yoo J, Fung K, Lang P, Palma DA, Mymryk JS, Barrett JW, Patel KB, Boutros PC, Nichols AC. Analysis of the TCGA Dataset Reveals that Subsites of Laryngeal Squamous Cell Carcinoma are Molecularly Distinct. Cancers (Basel). 2020 Dec.13(1). Pubmedid: 33396315. Pmcid: PMC7794818.
  • Koenigs MB, Lefranc-Torres A, Bonilla-Velez J, Patel KB, Hayes DN, Glomski K, Busse PM, Chan AW, Clark JR, Deschler DG, Emerick KS, Hammon RJ, Wirth LJ, Lin DT, Mroz EA, Faquin WC, Rocco JW. Association of Estrogen Receptor Alpha Expression With Survival in Oropharyngeal Cancer Following Chemoradiation Therapy. J Natl Cancer Inst. 2019 Sep.111(9):933-942. Pubmedid: 30715409. Pmcid: PMC6748818.
  • Patel KB, Naik AN, Kang SY, Old MO. Aberrant Superficial Branch of the Radial Nerve-Radial Forearm Free Flap Considerations. Plast Reconstr Surg Glob Open. 2019 Jun.7(6):e2191. Pubmedid: 31624666. Pmcid: PMC6635202.
  • Mundi N, Patel KB, Yeh DH, Nichols AC. Closure of tracheocutaneous fistula using prefabricated conchal bowl cartilage and a supraclavicular flap. J Laryngol Otol. 2019 Jul.133(8):727-729. Pubmedid: 31284887.
  • Mundi N, Prokopec SD, Ghasemi F, Warner A, Patel K, MacNeil D, Howlett C, Stecho W, Plantinga P, Pinto N, Ruicci KM, Khan MI, Han MW, Yoo J, Fung K, Sahovaler A, Palma DA, Winquist E, Mymryk JS, Barrett JW, Boutros PC, Nichols AC. Genomic and human papillomavirus profiling of an oral cancer cohort identifies TP53 as a predictor of overall survival. Cancers Head Neck. 2019 Dec.4:5. Pubmedid: 31844556. Pmcid: PMC6894507.
  • Patel KB, Lin C, Kramer S, Fada C, Ozer E. Transoral robotic excision of laryngocele: Surgical considerations. Head Neck. 2019 Apr.41(4):1140-1143. Pubmedid: 30652374.
  • Patel KB, Nichols AC, Fung K, Yoo J, MacNeil SD. Treatment of early stage Supraglottic squamous cell carcinoma: meta-analysis comparing primary surgery versus primary radiotherapy. J Otolaryngol Head Neck Surg. 2018 Mar.47(1):19. Pubmedid: 29506564. Pmcid: PMC5839014.
  • Kang SY, Eskander A, Patel K, Teknos TN, Old MO. The unique and valuable soft tissue free flap in head and neck reconstruction: Lateral arm. Oral Oncol. 2018 Jul.82:100-107. Pubmedid: 29909883.
  • van der Woerd B, Patel KB, Nichols AC, Fung K, Yoo J, MacNeil SD. Functional outcomes in early (T1/T2) supraglottic cancer: a systematic review. J Otolaryngol Head Neck Surg. 2018 Dec.47(1):76. Pubmedid: 30563567. Pmcid: PMC6299571.
  • MacNeil SD, Patel K, Liu K, Shariff S, Yoo J, Nichols A, Fung K, Garg AX. Survival of patients with subglottic squamous cell carcinoma. Curr Oncol. 2018 Dec.25(6):e569-e575. Pubmedid: 30607125. Pmcid: PMC6291284.
  • Pinto N, Black M, Patel K, Yoo J, Mymryk JS, Barrett JW, Nichols AC. Genomically driven precision medicine to improve outcomes in anaplastic thyroid cancer. J Oncol. 2014 Oct.2014:936285. Pubmedid: 25276134. Pmcid: PMC4170827.

Grants

Title: Pilot Assessment of Remote Symptom Reporting System in Head and Neck Cancer Patients
Sponsor: Moffitt Cancer Center
PI: Patel, K., CO-PI: Gonzalez, B.

Patient Comments
Overall Satisfaction
4.8
★★★★★
★★★★★

128 patients rated this provider

The Provider Rating is an average of all responses to specific care provider-related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. These surveys assess the experience of our patients when visiting us for an Outpatient Clinic, Urgent Care or Virtual Health (Telemedicine) visit. Responses are measured on a scale of 1 to 5 with 5 being the best score.

Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Learn more about our patient satisfaction survey

Comments ()

Comments are gathered from specific care provider-related questions from our Patient Satisfaction Survey . The comments are submitted by patients and reflect their views and opinions. Patients are de-identified for confidentiality and patient privacy.

We post both positive and negative comments from the surveys. We do not post comments that are libelous, slanderous, profane, irrelevant or otherwise inappropriate or may risk the privacy of our patients. A “[…]” in the comments below indicates de-identified patient information or comments that are unrelated to the patient’s experience with the visit to the provider, such as comments related to another provider, about the survey itself, or otherwise completely off-topic.

Not all providers will have a star rating or comments. In order to ensure accuracy of our ratings, we only display ratings for providers who have a minimum of 30 completed from the previous 12 months.

Learn more about our patient comments

Provider Ratings and comments are gathered from our nationally-recognized Press Ganey Patient Satisfaction Survey. If a provider does not have ratings or comments listed it can be for several reasons, including:

  • The provider has not yet received the minimum number of patient satisfaction surveys to be eligible for display. We require a minimum of 30 surveys before we post results to ensure that the rating is statistically reliable and a true reflection of patient satisfaction.
  • He or she may be a researcher or other type of provider that does not see patients.
  • The provider practices in a specialty or office that does not use the specified surveys currently used for these ratings.
Learn more about our patient satisfaction survey, ratings and comments